Tuesday’s Midday Stock Update: Brainstorm Cell Therapeutics (BCLI), Canadian Solar (CSIQ), Aerie Pharma (AERI), General Motors (GM), Organovo Holdings (ONVO)

So far Tuesday, October 20, NASDAQ is up 4.58% and the S&P is up 3.18%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Brainstorm Cell Therapeutics (BCLIResearch Report), Canadian Solar (CSIQResearch Report), Aerie Pharma (AERIResearch Report), General Motors (GMResearch Report) and Organovo Holdings (ONVOResearch Report).

Brainstorm Cell Therapeutics is down -17.26% in midday trading to $10.26. Shares opened today at $12.40. The company has a 52-week low of $3.58 and a 52-week high of $17.95. On the Street’s front, the average 12-month analyst price target for the stock is $20.00, marking a 61.29% potential upside from current levels. In a report issued on October 15, Maxim Group analyst Jason McCarthy assigned a Buy rating on BCLI, with a price target of $20.00, which implies an upside of 61% from current levels.

Canadian Solar is up 9.74% in midday trading to $43.62. Shares opened today at $39.75. The company has a 52-week low of $12.00 and a 52-week high of $42.74. On the Street’s front, the average 12-month analyst price target for the stock is $33.60, marking a -15.47% potential downside from current levels. In a report issued on August 28, GLJ Research analyst Gordon Johnson initiated coverage with a Buy rating on CSIQ and a price target of $49.40, which represents a potential upside of 24% from where the stock is currently trading. Separately, on August 14, UBS’s Jon Windham maintained a Hold rating on the stock and has a price target of $24.00.

Aerie Pharma is down -7.42% in midday trading to $9.36. Shares opened today at $10.11. The company has a 52-week low of $9.86 and a 52-week high of $26.26. On the Street’s front, the average 12-month analyst price target for the stock is $24.25, marking a 139.86% potential upside from current levels. In a report released yesterday, Merrill Lynch analyst Jason Gerberry downgraded AERI to Sell, with a price target of $9.00, which reflects a potential downside of -11% from last closing price. Separately, on the same day, Raymond James’ Elliot Wilbur maintained a Hold rating on the stock .

See today’s analyst top recommended stocks >>

General Motors is up 6.27% in midday trading to $36.09. Shares opened today at $33.96. The company has a 52-week low of $14.33 and a 52-week high of $38.96. On the Street’s front, the average 12-month analyst price target for the stock is $40.33, marking a 18.76% potential upside from current levels. In a report released today, Citigroup analyst Itay Michaeli maintained a Buy rating on GM, with a price target of $57.00, which represents a potential upside of 68% from where the stock is currently trading. Separately, on September 10, Nomura’s Anindya Das maintained a Hold rating on the stock and has a price target of $27.00.

See today’s analyst top recommended stocks >>

Organovo Holdings is down -6.11% in midday trading to $8.45. Shares opened today at $9.00. The company has a 52-week low of $3.87 and a 52-week high of $18.60.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.